STAT

Medical schools are starting to diversify. But they’re learning hard lessons along the way

The enrollment of nonwhite students in medical schools has been steadily increasing, but there remain huge gaps between doctors and the communities they serve.

As medical students graduate this spring, American medical schools are celebrating the achievements of the nation’s newest doctors. They are also celebrating something else: an increase in the number of students from underrepresented populations.

From 2017 to 2018, the number of black students enrolled in U.S. medical schools rose by 4.6%, while the number of medical students identifying as American Indian or Alaska Native increased by 6.3%, according to data released by the Association of American Medical Colleges. It’s the latest evidence of a steady increase in the enrollment of nonwhite students over the past several years.

The numbers are encouraging, but only a start, educators say.

“It’s good that the hard numbers are up,” said Dr. Mark Henderson, associate dean of admissions at the University of California, Davis. “But there are real gaps between who our residents are and the communities they serve.”

The increases are also no accident.

In the seven years leading up to 2009, the number. Specifically, the group went beyond its previous suggestion that medical schools “should have policies and practices ensuring the gender, racial, cultural, and economic diversity of its students.”

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Abortion Pill Arguments, A Merck Drug Approval, And More
U.S. Supreme Court justices focused on plaintiffs' right to sue the FDA to reinstate restrictions on a commonly used abortion pill, suggesting they are unlikely to restrict access.
STAT1 min read
STAT+: New Gene Therapy, To Be Priced At $4.25 Million, Has Already Transformed Children’s Lives
The world's most expensive treatment offers a near-cure for young children and redemption for its developer, but steep challenges still loom.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CAR-T Drugs For Myeloma, CVS Rebate Credits, And More
A FDA panel voted in favor of expanding use of CAR-T therapy in multiple myeloma, despite concerns about side effects.

Related Books & Audiobooks